stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Rocket Pharmaceuticals IncRCKT
$2.166.09%-0.14

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc stock is traded at $2.16, with a volume of 1,919,497. It is down -6.09% in the last 24 hours and down -0.92% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Previous Close:
$2.30
Open:
$2.28
24h Volume:
1,919,497
Relative Volume:
1.27
Market Cap:
$241.19M
Revenue:
-
Net Income/Loss:
-$209.38M
P/E Ratio:
-
EPS:
-$1.88
Net Cash Flow:
-$179.81M
1W Performance:
-14.62%
1M Performance:
-0.92%
6M Performance:
-33.54%
1Y Performance:
-29.18%
1-Day Range:
$2.15$2.35
1-Week Range:
$2.15$2.55
52-Week Range:
$2.15$5.45

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Rocket Pharmaceuticals Inc
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY, USA
Employee
202
Next Earnings Date
-
Latest SEC Filings
SEC
RCKT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data

Similar to RCKT